Myobloc

Active Ingredient(s): Botulinum Toxin Type B
FDA Approved: * December 8, 2000
Pharm Company: * ELAN PHARM
Category: Neurological Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Myobloc Overview

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species.[1] It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research. Botulinum is the most acutely lethal toxin known, with an estimated human median lethal...

Read more Myobloc Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Botulinum_toxin

Recent Myobloc Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Myobloc: (3 results)

Sorted by National Drug Code

• 10454-710 Myobloc 2500 [usp'u]/.5ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC
• 10454-711 Myobloc 5000 [usp'u]/Ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC
• 10454-712 Myobloc 10000 [usp'u]/2ml Intramuscular Injection, Solution by Solstice Neurosciences, LLC

Other drugs which contain Botulinum Toxin Type B or a similar ingredient: (1 result)

• BOTULINUM TOXIN TYPE B